Clinical Trial Update: A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating the combination of trametinib and azacitidine for newly diagnosed juvenile myelomonocytic leukemia (JMML) is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cbl Syndrome
• Juvenile Myelomonocytic Leukemia
• Leukemia
• Neurofibromatosis Type

Drugs mentioned

• Trametinib (trametinib)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Leukemia, Juvenile Myelomonocytic, JMML | Phase 1, Phase 2 | Status: RECRUITING